Table 3.
Absolute difference in the proportion of study outcomes in the 12-month pre- and postablation periods by race
| Admissions | White (N = 2669) |
Black (N = 141) |
Asian (N = 28) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre 12 months | Post 12 months | Absolute difference in proportion (%) | Pre 12 months | Post 12 months | Absolute difference in proportion (%) | Pre 12 months | Post 12 months | Absolute difference in proportion (%) | |
| Inpatient∗ | 352 (13.2) | 151 (5.7) | –7.5 (–9.1 to –5.9) | 26 (18.4) | 9 (6.4) | –12.0 (–20.3 to –3.8) | 4 (14.3) | 2 (7.1) | –7.2 (–26.8 to 12.5) |
| Outpatient∗ | 1538 (57.6) | 945 (35.4) | –22.2 (–24.9 to –19.6) | 59 (41.8) | 27 (19.1) | –22.7 (–33.8 to –11.6) | 16 (57.1) | 9 (32.1) | –25.0 (–53.8 to 3.8) |
| ED∗ | 96 (3.6) | 42 (1.6) | –2.0 (–2.9 to –1.1) | 2 (1.4) | 2 (1.4) | –0.0 (–2.8 to 2.8) | 2 (7.1) | 1 (3.6) | –3.5 (–18.9 to 11.8) |
| DCCV | 938 (35.1) | 361 (13.5) | –21.6 (–23.9 to –19.4) | 31 (22.0) | 6 (4.3) | –17.7 (–26.0 to –9.4) | 7 (25.0) | 4 (14.3) | –10.7 (–34.9 to 13.5) |
| Composite | 1690 (63.3) | 1015 (38.0) | –25.3 (–27.9 to –22.7) | 71 (50.4) | 34 (24.1) | –26.3 (–37.8 to –14.7) | 18 (64.3) | 9 (32.1) | –32.2 (–60.5 to –3.8) |
Values are given as n (%) or 95% confidence interval.
Abbreviations as in Table 2.
∗
Atrial fibrillation-related admissions.